MyMelanoma study selected to join NHS DigiTrials initiative
Source: Oxford Cancer, November 2024
Three projects – including the Oxford-led MyMelanoma study – have been selected to join an NHS initiative, which aims to sign up tens of thousands of volunteers over the next two years to help improve the diagnosis and treatment of cancer patients.
Launched in 2023, the MyMelanoma study is the most ambitious melanoma research project undertaken in the UK. Led by the University of Oxford and managed through Oxford Cancer, it aims to recruit 20,000 UK melanoma patients in order to carry out the largest study of melanoma ever performed, to improve understanding of melanoma skin cancer and its treatment.
MyMelanoma has been selected as one of three cancer-focussed studies (alongside a fourth seeking to improve the care of young children needing complex surgery) to pilot the new NHS DigiTrials recruitment service, which is managed by NHS England. The service aims to identify NHS patients who might be suitable for a certain trial and contacts them to see if they would like to take part.